TownSquare Capital’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,559
Closed -$12.2K 883
2025
Q1
$12.2K Sell
10,559
-70
-0.7% -$103 ﹤0.01% 1677
2024
Q4
$13.5K Sell
10,629
-19,294
-64% -$49.2K ﹤0.01% 1558
2024
Q3
$102K Buy
29,923
+18,831
+170% +$82K ﹤0.01% 1429
2024
Q2
$51.8K Buy
+11,092
New +$62.6K ﹤0.01% 1269

Other funds holding EDIT

TownSquare Capital's EDIT Position: Q2 2025 in Review

TownSquare Capital sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 10,559 shares — an estimated $12.2K sold.

TownSquare Capital first reported a position in EDIT in Q2 2024 and held it in 4 quarters. The position peaked at $102K in Q3 2024. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • TownSquare Capital reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • TownSquare Capital sold 10,559 Editas Medicine shares in Q2 2025, an estimated $12.2K.
  • TownSquare Capital first reported a position in Editas Medicine in Q2 2024 and held it in 4 quarters.
  • TownSquare Capital's Editas Medicine position peaked at $102K in Q3 2024.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on TownSquare Capital's 13F filing for Q2 2025, filed 13 Aug 2025.